Ignite Creation Date:
2025-12-24 @ 10:55 PM
Ignite Modification Date:
2025-12-25 @ 8:23 PM
Study NCT ID:
NCT01816269
Status:
UNKNOWN
Last Update Posted:
2013-03-22
First Post:
2013-03-20
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Effect of Dental Scaling on Helicobacter Pylori Eradication and Reinfection
Sponsor:
Goztepe Training and Research Hospital
Organization:
Study Overview
Official Title:
Effect of Dental Scaling on Helicobacter Pylori Eradication and Reinfection
Status:
UNKNOWN
Status Verified Date:
2013-03
Last Known Status:
ENROLLING_BY_INVITATION
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Scaling and Hp
Brief Summary:
Patients who had received H.pylori eradication treatment will be categorised as eradication and reinfection status and whether dental scaling has any influence on these results.
Detailed Description:
Patients over 18 years with no comorbidities especially liver, cardiac and haemorrhagic diathesis and giving informed consent will be categorised according to their status of dental scaling, eradication and reinfection rates of h.pylori.
Statistical examination will include the multiple regression and Chi-Square.
The result will emphasize the influence of dental scaling on eradication (Presence of Hp cure 1-6 months after treatment) and reinfection ( reappearance of Hp 12 months later than the treatment).
Statistical examination will include the multiple regression and Chi-Square.
The result will emphasize the influence of dental scaling on eradication (Presence of Hp cure 1-6 months after treatment) and reinfection ( reappearance of Hp 12 months later than the treatment).
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: